Comprehensive characterization of COVID-19 patients with repeatedly positive SARS-CoV-2 tests using a large US electronic health record database
Xiao Dong, Yujia Zhou, Xiao-ou Shu, Elmer V. Bernstam, Rebecca Stern, David M. Aronoff, Hua Xu, Loren Lipworth
doi: https://doi.org/10.1101/2021.06.10.21256915
Xiao Dong
1School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX
Yujia Zhou
1School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX
Xiao-ou Shu
2Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
PhDElmer V. Bernstam
1School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX
3Division of General Internal Medicine, Department of Internal Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX
MD, MSRebecca Stern
4Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
MDDavid M. Aronoff
4Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
MDHua Xu
1School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX
PhDLoren Lipworth
2Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
ScDData Availability
Optum's COVID-19 data are available for researchers for approved research purposes. By negotiation with Optum, the dataset is potentially accessible to any qualified investigator within the University of Texas System. It can be used in conjunction with grants, but as required by Optum, not for pharmaceutical industry-funded projects. University of Texas Health Science Center-Houston. Center for Healthcare Data (CHCD). https://dataportal.uta.edu/node/27. Published 2021. Accessed May 6, 2021
Posted June 13, 2021.
Comprehensive characterization of COVID-19 patients with repeatedly positive SARS-CoV-2 tests using a large US electronic health record database
Xiao Dong, Yujia Zhou, Xiao-ou Shu, Elmer V. Bernstam, Rebecca Stern, David M. Aronoff, Hua Xu, Loren Lipworth
medRxiv 2021.06.10.21256915; doi: https://doi.org/10.1101/2021.06.10.21256915
Comprehensive characterization of COVID-19 patients with repeatedly positive SARS-CoV-2 tests using a large US electronic health record database
Xiao Dong, Yujia Zhou, Xiao-ou Shu, Elmer V. Bernstam, Rebecca Stern, David M. Aronoff, Hua Xu, Loren Lipworth
medRxiv 2021.06.10.21256915; doi: https://doi.org/10.1101/2021.06.10.21256915
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)